FDA Inspection 1242707 — Median Technologies

Median Technologies — FEI 3005312556

The FDA completed an inspection of Median Technologies on May 16, 2024 in Valbonne. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Valbonne (France)

Additional Details

Sponsor, Contract Research Organization